Comparable stake leader
BAKER BROS. ADVISORS LP
SEC ownership of Replimune Group, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001737953.
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
50/50
Latest evidence
14 May 2026
- Symbol
- REPL on Nasdaq
- SEC evidence covered
- 3/4/5, 13D/G, and 13F
- Largest SEC-reported holder
- BAKER BROS. ADVISORS LP
- Latest 13D/G holder
- BAKER BROS. ADVISORS LP
- Latest parsed evidence date
- 14 May 2026
- CIK
- 0001737953
- Location
- Woburn, MA
Ownership snapshot
2 signals
Issuer
2 identity fields
Ownership snapshot
Top shareholders of Replimune Group, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
50/50
Latest evidence
14 May 2026
3/4/5
13D/G
13F
Lead comparable stake: 14%
13D/G row: BAKER BROS. ADVISORS LP
Showing 1-8 of 50 holder rows.
Quick read
BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 14%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BAKER BROS. ADVISORS LP
14%
RTW INVESTMENTS, LP
8.9%
Ridgeback Capital Investments L.P.
7.6%
SUVRETTA CAPITAL MANAGEMENT, LLC
5.1%
VANGUARD GROUP INC
4.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
3/4/5
13D/G
13F
Director, 10%+ Owner · Company
|
14%
from 13D/G
|
$125,641,900
10,160,595 shares
mixed-class rows
|
— | 01 Apr 2026 |
| RTW INVESTMENTS, LP |
13F
13D/G
Company
|
8.9%
from 13D/G
|
$56,280,407
7,356,916 shares
|
— | 31 Mar 2026 |
| Ridgeback Capital Investments L.P. |
13D/G
|
7.6%
|
$11,629,931
6,252,651 shares
|
$0 | 14 May 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
13D/G
Company
|
5.1%
from 13D/G
|
$32,297,045
4,221,836 shares
|
— | 31 Mar 2026 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
4.8%
|
$32,542,424
3,595,848 shares
|
$0 | 31 Dec 2024 |
| Point72 Asset Management, L.P. |
13D/G
|
4.7%
|
$15,209,289
3,629,902 shares
|
-$3,488,586 | 30 Sep 2025 |
| Forbion Capital Fund III Cooperatief U.A. |
13D/G
|
3.5%
|
$22,579,279
2,808,368 shares
|
-$11,344,215 | 31 Dec 2025 |
| Redmile Group, LLC |
13D/G
|
0.7%
|
$2,245,077
535,818 shares
|
-$18,279,751 | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$832,976.
Buys
$0
Insiders: 0
Sells
$832,976
Insiders: 7
Net
-$832,976
Shares: -134,615
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 134,615
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 99,836 | $0 | $526,212 | -$526,212 |
| 3-6 | 0 | 3,169 | $0 | $32,958 | -$32,958 |
| 6-9 | 0 | 22,456 | $0 | $224,650 | -$224,650 |
| 9-12 | 0 | 9,154 | $0 | $49,157 | -$49,157 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 29 reporting-owner rows connected to Replimune Group, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
29
Largest Forms 3/4/5 holder
BAKER BROS. ADVISORS LP
Net 12M change
-$832,978
Latest report
18 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | Director, 10%+ Owner | $125,641,900 | Mixed | 01 Apr 2026 | ||
| Omega Fund IV, L.P. | 10%+ Owner | $103,049,420 | Mixed | 14 Mar 2022 | ||
| Robert Coffin | Director | $11,787,512 | Filing P/S | 16 May 2024 | ||
| Philip Astley-Sparke | Director | $7,175,063 | -$89,698 | -1.2% | Filing P/S | 18 May 2026 |
| Colin Love | Chief Operating Officer | $5,029,422 | Filing P/S | 16 May 2024 | ||
| Sushil Patel | Chief Executive Officer, Director | $3,797,259 | -$300,906 | -7.3% | Filing P/S | 18 May 2026 |
| Pamela Esposito | Chief Business Officer | $2,876,721 | Mixed | 11 Sep 2023 | ||
| Tanya Lewis | Chief Dev. Op. Officer | $1,477,400 | Mixed | 13 Jun 2023 | ||
| Jean M. Franchi | Chief Financial Officer | $1,405,928 | Mixed | 16 May 2023 | ||
| Emily Luisa Hill | Chief Financial Officer | $1,201,704 | -$88,842 | -6.9% | Filing P/S | 18 May 2026 |
| Konstantinos Xynos | Chief Medical Officer | $1,197,162 | -$137,194 | -10% | Filing P/S | 18 May 2026 |
| Christopher Sarchi | Chief Commercial Officer | $980,246 | -$143,278 | -13% | Filing P/S | 18 May 2026 |
| Andrew Schwendenman | Chief Accounting Officer | $543,849 | -$40,102 | -6.9% | Filing P/S | 18 May 2026 |
| Kapil Dhingra | Director | $0 | -$32,958 | -100% | Mixed | 01 Apr 2026 |
| Hugo Alexander Slootweg | Director | Mixed | 01 Apr 2023 | |||
| Christy J. Oliger | Director | Mixed | 01 Apr 2026 | |||
| Veleka Peeples-Dyer | Director | Mixed | 01 Apr 2026 | |||
| Hyam Levitsky | Director | Mixed | 01 Apr 2024 | |||
| Baker Bros. Advisors (GP) LLC | Director, 10%+ Owner | Mixed | 01 Apr 2026 | |||
| 667, L.P. | Director, 10%+ Owner | Mixed | 01 Apr 2026 |
Recent insider transactions for Replimune Group, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Konstantinos Xynos | REPL | Common Stock | Sale | -5.62% | $71,237 | $5.08 | -14,023 | 235,662 | 18 May 2026 | Direct |
| Andrew Schwendenman | REPL | Common Stock | Sale | -6.87% | $40,102 | $5.08 | -7,894 | 107,057 | 18 May 2026 | Direct |
| Christopher Sarchi | REPL | Common Stock | Sale | -4.28% | $43,820 | $5.08 | -8,626 | 192,962 | 18 May 2026 | Direct |
| Philip Astley-Sparke | REPL | Common Stock | Sale | -1.23% | $89,698 | $5.08 | -17,657 | 1,412,414 | 18 May 2026 | Direct |
| Sushil Patel | REPL | Common Stock | Sale | -4.76% | $189,606 | $5.08 | -37,324 | 747,492 | 18 May 2026 | Direct |
| Emily Luisa Hill | REPL | Common Stock | Sale | -3.2% | $39,685 | $5.08 | -7,812 | 236,556 | 18 May 2026 | Direct |
| Christopher Sarchi | REPL | Common Stock | Sale | -4.11% | $52,065 | $8.01 | -6,500 | 151,588 | 02 Apr 2026 | Direct |
| BAKER BROS. ADVISORS LP | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| BAKER BROS. ADVISORS LP | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Christopher Sarchi | REPL | Common Stock | Award | 33% | 50,000 | 201,588 | 01 Apr 2026 | Direct | ||
| Christopher Sarchi | REPL | Employee Stock Option (right to buy) | Award | 75,000 | 75,000 | 01 Apr 2026 | Direct | |||
| Philip Astley-Sparke | REPL | Common Stock | Award | 3.62% | 50,000 | 1,430,071 | 01 Apr 2026 | Direct | ||
| Philip Astley-Sparke | REPL | Stock Option (right to buy) | Award | 75,000 | 75,000 | 01 Apr 2026 | Direct | |||
| Christy J. Oliger | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Konstantinos Xynos | REPL | Common Stock | Award | 25% | 50,000 | 249,685 | 01 Apr 2026 | Direct | ||
| Konstantinos Xynos | REPL | Employee Stock Option (right to buy) | Award | 75,000 | 75,000 | 01 Apr 2026 | Direct | |||
| Madhavan Balachandran | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Andrew Schwendenman | REPL | Common Stock | Award | -24.2% | -36,667 | 114,951 | 01 Apr 2026 | Direct | ||
| Andrew Schwendenman | REPL | Employee Stock Option (right to buy) | Award | 55,000 | 55,000 | 01 Apr 2026 | Direct | |||
| Sushil Patel | REPL | Common Stock | Award | 47.1% | 251,240 | 784,816 | 01 Apr 2026 | Direct | ||
| Sushil Patel | REPL | Employee Stock Option (right to buy) | Award | 376,860 | 376,860 | 01 Apr 2026 | Direct | |||
| Kapil Dhingra | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Paolo Pucci | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Joseph P. Slattery | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Veleka Peeples-Dyer | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Emily Luisa Hill | REPL | Common Stock | Award | 25.7% | 50,000 | 244,368 | 01 Apr 2026 | Direct | ||
| Emily Luisa Hill | REPL | Employee Stock Option (right to buy) | Award | 75,000 | 75,000 | 01 Apr 2026 | Direct | |||
| Dieter Weinand | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Philip Astley-Sparke | REPL | Common Stock | Gift | -1.78% | -25,000 | 1,380,071 | 18 Feb 2026 | Direct | ||
| Sushil Patel | REPL | Common Stock | Award | 60% | 200,000 | 533,576 | 19 Dec 2025 | Direct | ||
| Konstantinos Xynos | REPL | Common Stock | Award | 43% | 60,000 | 199,685 | 19 Dec 2025 | Direct | ||
| Emily Luisa Hill | REPL | Common Stock | Award | 44.6% | 60,000 | 194,368 | 19 Dec 2025 | Direct | ||
| Christopher Sarchi | REPL | Common Stock | Award | 28.4% | 35,000 | 158,088 | 19 Dec 2025 | Direct | ||
| Andrew Schwendenman | REPL | Common Stock | Award | 14.6% | 10,000 | 78,284 | 19 Dec 2025 | Direct | ||
| Kapil Dhingra | REPL | Common Stock | Sale | -100% | $32,958 | $10.40 | -3,169 | 0 | 09 Dec 2025 | Direct |
| Kapil Dhingra | REPL | Common Stock | Options Exercise | 3,169 | 3,169 | 09 Dec 2025 | Direct | |||
| Kapil Dhingra | REPL | Stock Option (right to buy) | Options Exercise | -100% | -3,169 | 0 | 09 Dec 2025 | Direct | ||
| Sushil Patel | REPL | Common Stock | Sale | -2.91% | $111,300 | $11.13 | -10,000 | 333,576 | 02 Dec 2025 | Direct |
| Christopher Sarchi | REPL | Common Stock | Sale | -4.06% | $47,393 | $9.10 | -5,208 | 123,088 | 17 Nov 2025 | Direct |
| Konstantinos Xynos | REPL | Common Stock | Sale | -4.93% | $65,957 | $9.10 | -7,248 | 139,685 | 17 Nov 2025 | Direct |
| Emily Luisa Hill | REPL | Common Stock | Sale | -6.38% | $49,157 | $5.37 | -9,154 | 134,368 | 15 Aug 2025 | Direct |
* marks a reported price that did not pass the local price check.